Clobetasol Propionate
Pricing Report NDC 0378-8167-01

Latest NADAC: $0.30038 per GM · Effective Oct 18, 2023 · Est. package price $30.04 (100 GM)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Clobetasol Propionate (NDC 0378-8167-01) is $0.30038 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Oct 18, 2023.

As a provided by Mylan Pharmaceuticals Inc., this medication is distributed in a 100 g in 1 CAN configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.30038
Per GM

Effective Date
Oct 18, 2023
Billable Units
100 GM
Estimated Package Price
$30.04
Data Status
As of Nov 08, 2023
C/I - Chain or Independent Pharmacy
Package NDC
Description
100 g in 1 CAN
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2019, the NADAC wholesale price for (NDC ) has moved within a range of $0.30038 to $2.12785 per GM. Over this 4 years and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.3004 - $1.9794
Market Volatility
558.95% Variance
Latest Trend
33.28%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Oct 18, 2023 $0.30038 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 18, 2023 $0.43154 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 20, 2023 $0.45020 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 20, 2023 $0.43151 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 23, 2023 $0.39775 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 23, 2023 $0.37211 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 19, 2023 $0.36391 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 19, 2023 $0.43023 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 21, 2023 $0.46954 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 21, 2023 $0.63593 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 17, 2023 $0.50519 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 17, 2023 $0.43801 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026